Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
3.2K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.6K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

9.6K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.6K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

7.6K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.6K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

5.6K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Biomimetic Amelogenin-Fibronectin Fusion Protein with Dual Cell-Adhesive and Osteoinductive Functions for Alveolar Bone Defect Repair.

Bioengineering (Basel, Switzerland)·2026
Same author

Micro-Galvanic Coupling Programs the Therapeutic Zinc Ion Window to Reconfigure Immune Cascades for Pro-Regenerative Bone Healing.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Design of Safe and Efficient Adenine Base Editors via Protein Language Model Screening for Osteoarthritis Treatment.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

A peptide immunomodulator activates MST1 to expand and stabilize murine and human regulatory T cells for immune tolerance.

Science translational medicine·2026
Same author

Implantation awakens peri-implant osteogenic potential via Snx5-EGFR axis-mediated mechanical transduction.

International journal of oral science·2026
Same author

Histone H3K27 acetylation of slc25a4 mediates triclocarban-induced transgenerational developmental toxicity in zebrafish (Danio rerio) at subthreshold exposure.

Environmental research·2026

Related Experiment Video

Updated: Dec 14, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.0K

The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts.

Yao Sun1, Mingxiang Cai2, Jiayong Zhong3,4,5,6

  • 1Department of Oral Implantology, School of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China. yaosun@tongji.edu.cn.

Nature Metabolism
|July 23, 2020
PubMed
Summary

Long noncoding RNAs (lncRNAs) regulate bone formation. This study identifies lnc-ob1 as a key regulator of osteoblast activity and bone mass, offering potential therapeutic targets for osteoporosis.

More Related Videos

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
09:20

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Published on: December 18, 2019

7.4K
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.0K

Related Experiment Videos

Last Updated: Dec 14, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.0K
Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
09:20

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Published on: December 18, 2019

7.4K
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.0K

Area of Science:

  • Molecular Biology
  • Genetics
  • Bone Biology

Background:

  • Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in biological processes.
  • The specific functions of lncRNAs in bone metabolism and disease are not well understood.
  • Osteoporosis is a significant public health concern characterized by low bone mass and increased fracture risk.

Purpose of the Study:

  • To investigate the role of lnc-ob1, a novel long noncoding RNA, in regulating osteoblast activity and bone formation.
  • To explore the potential of lnc-OB1 as a therapeutic target for osteoporosis.

Main Methods:

  • Expression analysis of lnc-ob1 in osteoblasts during osteoblastogenesis.
  • Generation of osteoblast-specific lnc-ob1 knock-in mouse models.
  • Assessment of bone formation and bone mass in genetically modified mice.
  • Evaluation of lnc-ob1's effect on osteoporosis induced by ovariectomy.
  • Analysis of lnc-OB1 expression in human osteoblasts from osteoporosis patients.
  • Mechanistic studies involving Osterix transcription factor and H3K27me3 methylation.

Main Results:

  • lnc-ob1 expression is enriched in osteoblasts and increases during osteoblastogenesis.
  • Osteoblast-specific overexpression of lnc-ob1 significantly enhances bone formation and increases bone mass in mice.
  • Pharmacological upregulation of lnc-ob1 in osteoblasts provides protection against ovariectomy-induced osteoporosis.
  • Human lnc-OB1 expression declines with age in osteoblasts of osteoporosis patients.
  • lnc-ob1 upregulates Osterix expression in both mouse and human osteoblasts, likely through H3K27me3 methylation inhibition.

Conclusions:

  • lnc-ob1 is a critical regulator of osteoblast function and bone formation.
  • lnc-OB1 plays a role in age-related bone loss and osteoporosis.
  • lnc-OB1 represents a promising therapeutic target for treating osteoporosis and related bone disorders.